The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons
Stem Cell Reports · 2024-02 · 19 (2) · 163-173
DOI: 10.1016/j.stemcr.2024.01.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2024-02. Verfasst von Adamantios Mamais und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Research in Neurodegenerative Disease and Fixel Institute for Neurologic Diseases, Department of Neurology, University of Fl…. Hauptthemen laut MEDLINE: alpha-Synuclein, rab GTP-Binding Proteins. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIA, Michael J. Fox Foundation for Parkinson's Research.
Abstract (Originalsprache)
Mutations in the LRRK2 gene cause familial Parkinson's disease presenting with pleomorphic neuropathology that can involve α-synuclein or tau accumulation. LRRK2 mutations are thought to converge upon a pathogenic increase in LRRK2 kinase activity. A subset of small RAB GTPases has been identified as LRRK2 substrates, with LRRK2-dependent phosphorylation resulting in RAB inactivation. We used CRISPR-Cas9 genome editing to generate a novel series of isogenic iPSC lines deficient in the two most well-validated LRRK2 substrates, RAB8a and RAB10, from deeply phenotyped healthy control lines. Thorough characterization of NGN2-induced neurons revealed opposing effects of RAB8a and RAB10 deficiency on lysosomal pH and Golgi organization, with isolated effects of RAB8a and RAB10 ablation on α-synuclein and tau, respectively. Our data demonstrate largely antagonistic effects of genetic RAB8a or RAB10 inactivation, which provide discrete insight into the pathologic features of their biochemical inactivation by pathogenic LRRK2 mutation in human disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Translational Research in Neurodegenerative Disease and Fixel Institute for Neurologic Diseases, Department of Neurology, University of Florida, Gainesville, FL, USA.
- Department of Cell Biology, Harvard Medical School, and Program in Cellular and Molecular Medicine, Boston Children's Hospital, Boston, MA, USA.
- Department of Neuroscience, University of Florida, Gainesville, FL, USA.
- F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
- Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Center for Translational Research in Neurodegenerative Disease and Fixel Institute for Neurologic Diseases, Department of Neurology, University of Florida, Gainesville, FL, USA; Department of Cell Biology, Harvard Medic…
Förderung
- NINDS NIH HHS
- NIA
- Michael J. Fox Foundation for Parkinson's Research
- National Institutes of Health
- NINDS
Zitieren
APA
Mamais, A., Sanyal, A., Fajfer, A., Zykoski, C. G., Guldin, M., Riley-DiPaolo, A., Subrahmanian, N., Gibbs, W., Lin, S., & LaVoie, M. J. (2024). The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons. Stem Cell Reports, 19(2), 163-173. https://doi.org/10.1016/j.stemcr.2024.01.001
Vancouver
Mamais A, Sanyal A, Fajfer A, Zykoski CG, Guldin M, Riley-DiPaolo A, et al. The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons. Stem Cell Reports. 2024;19(2):163-173. doi:10.1016/j.stemcr.2024.01.001
BibTeX
@article{Mamais2024,
author = {Mamais, Adamantios and Sanyal, Anwesha and Fajfer, Austin and Zykoski, Catherine G and Guldin, Michael and Riley-DiPaolo, Alexis and Subrahmanian, Nitya and Gibbs, Whitney and Lin, Steven and LaVoie, Matthew J},
title = {The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons},
journal = {Stem Cell Reports},
year = {2024},
volume = {19},
number = {2},
pages = {163--173},
doi = {10.1016/j.stemcr.2024.01.001}
}
EUVIMED